global burden of disease: methods and implications for indonesia 26 february 2014 sarah wulf, mph,...
TRANSCRIPT
Global Burden of Disease:Methods and Implications for Indonesia
26 February 2014
Sarah Wulf, MPH, PhD candidate
Research Associate
2
Is Mary healthier than Rosa?
3
Outline: Burden of Disease
MotivationWhy do we care about it?
MethodsHow do we measure it?
ImplicationsWhat do we do with the results?
Motivation: summarize population health
4
Primary goal: to have an accurate, comprehensive, and comparable summary of a population’s health
Historically, heavy dependence ono Mortality rates
o Life expectancy
for key decision making and planning
Do these metrics achieve the goal?
Then why this dependence?
Motivation: better health burden evidence
5
Understanding disease determinants and outcomes
Set research and
development priorities
Manage program
implementation
Establish health agendas
Monitor progress Evaluate what works and what does not
1
2
3
Motivation: Global Burden of Disease
6
• GBD is a systematic, scientific effort to quantify the comparative magnitude of health loss to diseases, injuries, and risk factors by age, sex, and geography over time
• GBD approacho Analyze all available sources of information and correct problems
with the data
o Measure health loss using a common metric for a comprehensive set of diseases, injuries, and risk factors
o Decouple epidemiological assessment and advocacy
o Inject non-fatal health outcomes into health policy debate
Teaser: Global Burden of Disease results
7
http://viz.healthmetricsandevaluation.org
http://viz.healthmetricsandevaluation.org/gbd-compare/
8
Teaser: Top 10 causes of Death in Indonesia
9
Teaser: Top 10 causes of DALYs in Indonesia
10
Outline: Burden of Disease
MotivationWhy do we care about it?
MethodsHow do we measure it?
ImplicationsWhat do we do with the results?
11
DALYs = YLLs + YLDs
Overall health loss
Health loss due to premature
mortality
Health loss due to living with disability
Methods: Overview
• GBD approach to measurement is different than many single disease, injury or risk factor studies.
• Differences are philosophical and technical. o Comprehensive Comparisons
o Estimating and Communicating Uncertainty
o Internal Consistency
o Iterative Approach to Estimation
12
A. Communicable, maternal, neonatal, and nutritional conditions
B. Non-communicable causes including cancers, diabetes, cardiovascular disorders and chronic respiratory diseases
C. Injuries, both unintentional and intentional
Three broad groups of causes of health loss
13
Cause List
o List of causes used to produce estimates of mortality, morbidity and burden
o Hierarchical structure of diseases and injuries
o 5 levels of aggregation
o Mutually exclusive categories in each level: add up to 100% of burden
o GBD 2010o 291 diseases and injuries and 1,160 sequelae
o Cause of death for 235 diseases and injuries
o Non-fatal estimates for 290 diseases and injuries and 1160 sequelae
14
Methods
1. Demographics
Population and all-cause mortality
2. Covariates
3. Cause of death burden
Years of Life Lost due to premature mortality (YLLs)
4. Non-fatal health burden by cause
Years Lived with Disability (YLDs)
5. Total burden
Disability-Adjusted Life Years (DALYs)
6. Risk factor attribution
15
Methods: Demographics
• Mortality rate = (deaths in an age group in a year) (population in an age group at the midpoint of the year)
• Commonly reported probabilities of death
1) 1q0 – infant mortality ‘rate’, the probability of death between birth and exact age 1.
2) 5q0 – child mortality, the probability of death between birth and exact age 5.
3) 45q15 – adult mortality, the probability of death between age 15 and exact age 60 conditional on being alive at age 15.
16
1
SWEDEN
Val
ue
Year1750 177518001825185018751900192519501975 2000
0
0.1
0.2
0.3
0.4
0.5
Male 5q0Female 5q0
Val
ue
Year1750 177518001825185018751900192519501975 2000
0
0.2
0.4
0.6
0.8
1
Male 45q15Female 45q15
250 Years of Child and Adult Mortality
17
1
Alternative Mortality Measurement Methods
1) Complete birth histories
2) Summary birth histories
3) Sibling survival
4) Household deaths in the last 12 months
5) Demographic surveillance systems
18
1
19
1
20
1
21
1
Methods
1. Demographics
Population and all-cause mortality
2. Covariates
3. Cause of death burden
YLLs
4. Non-fatal health burden by cause
YLDs
5. Total burden
DALYs
6. Risk factor attribution
22
Methods: Covariates
• A major component of GBD is making estimates if data are sparse or conflicting data from multiple sources
• Covariates help in modeling
• Database of 84 covariate topic areas and 179 variants of the covariates*
• Missing data addressed using spatial-temporal regression and Gaussian process regression
23
2
* The full list of covariates can be found in the supplementary appendix to the Lancet comment "GBD 2010: design, definition, and metrics" (http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(12)61899-6/fulltext)
Covariate: Lag-Distributed Income (LDI)• A composite of 7 different GDP
serieso IMF ID (2005 base year)
o Penn ID (2005 base year)
o WB ID (2005 base year)
o Maddison ID (1990 base year)
o WB USD (2005 base year)
o IMF USD (2005 base year)
o UN USD (2005 base year)
• Composite GDP smoothed over preceding 10 years to produce LDI
• Ref: James et al (http://www.pophealthmetrics.com/content/10/1/12)
IMF= International Monetary Fund
Penn=University of Pennsylvania
Meddison : Angus Maddison’s research homepage at the University of Groningen Department of Economics 24
1000
015
000
2000
025
000
3000
035
000
LD
I (I
$ pe
r ca
pita
)1940 1960 1980 2000 2020
Year
Lag Distributed Income Per Capita in Australia
2
25
Covariate:Alcohol (liters per capita)
FAO Food Balance Sheets, World Drink Trends
2
Methods
1. Demographics
Population and all-cause mortality
2. Covariates
3. Cause of death burden
YLLs
4. Non-fatal health burden by cause
YLDs
5. Total burden
DALYs
6. Risk factor attribution
26
Methods: Cause of death burden
27
3
1) Identify and obtain all published and unpublished sources of data on causes of death.
2) Assess and enhance data quality and comparability
3) Develop and apply models for 235 individual causes of death
4) CoDCorrect – develop final estimates for each age-sex-country-year where the sum of the 235 individual causes of death equals the age-sex specific all-cause mortality rate
Cause of Death Ensemble modeling
1) “CODEm” -- used for most causes
2) Develop a large range of plausible models for each cause – all combination of selected covariates tested. Models retained that are significant with coefficients in the expected direction. All permutations tested for four families of models: mixed effects log rates, mixed effects logit cause fractions, ST-GPR log rates, ST-GPR logit cause fractions.
3) Create combinations ‘ensembles’ of the best performing models
4) Statistical tests of out-of-sample predictive validity all models
5) Select the best performing model or ensemble of models
28
3
CoDCorrect Algorithm
oEstimates for each age-sex-country-year for the 235 causes are constrained to equal the demographic estimate of all cause mortality for that age-sex-country-year.
oThis rescaling is repeated1000 times to propagate the uncertainty in the estimates for each cause into the final results
29
3
YLL calculation
30
YLLs X = deaths X * e X
Years of life lost due to premature
mortality
Number of deaths at age x
Standard life expectancy at
age x
3
31
Standard life expectancy
Based on lowest mortality rates at each age observed in any population of 5M or more.
Most estimates for Japanese women
Same standard for men and women
Age Life expectancy (years)0 86•021 85•215 81•25
10 76•2715 71•2920 66•3525 61•4030 54•4635 51•5340 46•6445 41•8050 37•0555 32•3860 27•8165 23•2970 18•9375 14•8080 10•9985 7•6490 5•0595 3•31
100 2•23105 1•63
3
32
3
33
3
Methods
1. Demographics
Population and all-cause mortality
2. Covariates
3. Cause of death burden
YLLs
4. Non-fatal health burden by cause
YLDs
5. Total burden
DALYs
6. Risk factor attribution
34
Methods: Non-fatal burden by cause
35
YLDs = Prev * DW
Years lived with disability
Prevalence of condition
Disability weight
4
Methods: Non-fatal burden by cause
• Incidence rate = (number of new cases of a disease) (person-time of observation)
• Prevalence rate = (number of individuals with a disease) (population)
• Prevalence ≈ Incidence * Durationo assuming incidence/remission/mortality rates are relatively stable
over time and/or duration is short
36
4
37
Challenges of YLD estimation
Data sources
Uncertainty
• No single source of data for YLDs from all conditions
• Inconsistency and gaps in information
• Uncertainty from data itself, lack of data, disability weights
Process specifications
• Complex disease epidemiology
• Severity distributions of health states
• Comorbidity
4
38
YLD calculation
𝑌𝐿𝐷𝑠𝑑𝑖𝑠𝑒𝑎𝑠𝑒= ∑𝑠𝑒𝑞𝑢𝑒𝑙𝑎=𝑖
𝑗
𝑃𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒𝑖∗𝐷𝑖𝑠𝑎𝑏𝑙𝑖𝑡𝑦 h𝑊𝑒𝑖𝑔 𝑡𝑖
Prevalence:
─ Estimates of country-/year-/age-/sex-specific disease sequela prevalence
─ Identify and pool all usable data sources
Disability weights (DWs):
─ Estimates of the disability associated with each health state
─ GBD Disability Survey, 2012
4
39
Data sources
• Systematic literature reviews
• Population surveys
• Cancer registries
• Renal replacement therapy registries
• Hospital data
• Outpatient data
• Cohort follow-up studies
• Disease surveillance systems
4
40
Data adjustments
Data issue Adjustment
Inconsistent case definition
Measurement instrument bias
Non-representative population bias
Incompleteness
Selection bias
Outlier studies
Correct for at-risk population
Downweight
Adjust upwards
Crosswalk
4
41
Methods
• DisMod-MR
• Natural history models
• Geospatial models
• Back-calculation models
• Registration completeness models
4
42
DisMod
• Bayesian Disease Modeling statistical tool
• Performs crosswalks to adjust for methodological variation
• Incorporates assumptions to inform the model
• Borrows strength using covariates and super-region, region, and country random effects to inform regions/countries with little or no data
• Forces consistency among disease parameters
4
43
Three estimation strategies with DisMod
Direct estimation of disease sequelae
Maternal sepsis
Disability envelopes for etiological attribution
Otitis media Congenital Meningitis Other causes
Hearing loss
Disability envelopes for disease sequelae Diabetes mellitus
Diabetic neuropathy
Diabetic foot ulcer
Diabetic amputation
Uncomplicated diabetes
Diabetic retinopathy
4
44
DisMod output
• Epidemiological parameters estimated by:
oCountry
oYear
oAge
oSex
• Estimates repeated 1,000 times to define uncertainty
Need to build in reality of comorbidity
4
Comorbidity adjustment
45
1 Simulate comorbidity distribution
• Use prevalence and disability weights across hypothetical 20,000 people in each demographic group
2 Calculate combined disability weights (CDW)
where n = number of health states observed for individual i
3 Reaggregate by disease sequela
• Apportion CDWs to each of the contributing sequelae in proportion to the DW of a sequela on its own
4 Quantify uncertainty
• Repeat 1,000 times to estimate uncertainty
Comorbidity-adjusted YLDs with uncertainty
4
Methods
1. Demographics
Population and all-cause mortality
2. Covariates
3. Cause of death burden
YLLs
4. Non-fatal health burden by cause
YLDs
5. Total burden
DALYs
6. Risk factor attribution
46
47
DALYs = YLLs + YLDs
Overall health loss
Health loss due to premature
mortality
Health loss due to living with disability
Methods: Total burden5
Methods
1. Demographics
Population and all-cause mortality
2. Covariates
3. Cause of death burden
YLLs
4. Non-fatal health burden by cause
YLDs
5. Total burden
DALYs
6. Risk factor attribution
48
Methods: Risk factor attribution
49
6
GBD 2010 – risks quantifiedUnimproved water and sanitation
Unimproved water
Unimproved sanitation
Air pollution
Ambient particulate matter pollution
Household air pollution from solid fuels
Ambient ozone pollution
Other environmental risks
Residential radon
Lead exposure
Child and maternal undernutrition
Suboptimal breastfeeding
Non-exclusive breastfeeding
Discontinued breastfeeding
Childhood underweight
Iron deficiency
Vitamin A deficiency
Zinc deficiency
Tobacco smoking and secondhand smoke
Tobacco smoking
Second-hand smoke
Alcohol and other drugs
Alcohol use
Drug use (opioids, cannabis, amphetamines)
Physiological risks for chronic diseases
High fasting plasma glucose
High total cholesterol
High systolic blood pressure
High body mass index
Low bone mineral density
Sexual abuse and violence
Childhood sexual abuse
Intimate partner violence
50
6
Dietary risk factors and physical inactivity
Diet low in fruits
Diet low in vegetables
Diet low in whole grains
Diet low in nuts/seeds
Diet low in milk
Diet high in unprocessed red meat
Diet high in processed meat
Sugar-sweetened beverages
Diet low in fibre
Diet low in calcium
Diet low in seafood omega-3
Diet low in polyunsaturated fatty acid (PUFA)
Diet high in trans fatty acids
Diet high in sodium
Physical inactivity and low physical activity
Occupational exposures
Occupational exposure to asbestos
Occupational exposure to arsenic
Occupational exposure to benzene
Occupational exposure to beryllium
Occupational exposure to cadmium
Occupational exposure to chromium
Occupational exposure to diesel
Occupational exposure to formaldehyde
Occupational exposure to nickel
Occupational exposure to polycyclic aromatic hydrocarbons
Occupational exposure to second hand smoke
Occupational exposure to silica
Occupational exposure to sulfuric acid
Occupational exposure to asthmagens
Occupational exposure to particulates and gases
Occupational noise
Occupational risk factors for injury
Occupational low back pain
GBD 2010 – risks quantified (2)
51
6
Calculating risk factor burden
1. Select risk-outcome pairs;
2. Estimate exposure distributions to each risk factor in the population;
3. Estimate cause effect sizes: relative risk per unit of exposure for each risk-outcome pair;
4. Choose a counterfactual exposure distribution: theoretical minimum risk exposure distribution (TMRED); and
5. Compute attributable burden, including uncertainty.
52
6
Risk-outcome inclusion criteria
1. Likely importance of a risk factor to disease burden or policy;
2. Availability of sufficient data and methods to enable estimation of exposure distributions by country for at least one of the study periods;
3. Sufficient evidence for causal effect (convincing or probable evidence) and to estimate outcome-specific effect sizes; and
4. Evidence to support generalizability of effect sizes to populations other than those included in epidemiological studies.
53
6
Strengths of GBD methods
• Comprehensive Comparisons
• Estimating and Communicating Uncertainty
• Internal Consistency
• Iterative Approach to Estimation
54
55
Outline: Burden of Disease
MotivationWhy do we care about it?
MethodsHow do we measure it?
ImplicationsWhat do we do with the results?
56
Using GBD to Answer Four Questions
Comparable results across countries and over time allow for examination of 4 questions:
1) What are the main causes of health loss in a country today?
2) What causes are getting worse and which are improving?
3) Compared to a set of relevant countries, what causes have rates that are substantially higher (or lower)?
4) Compared to the lowest rates for each disease in the set of relevant countries, where is the greatest potential to reduce burden?
57
58
59
60
61
62
Key findings in Indonesia
• Strokeo Top cause of burden
o Opportunities for intervention: hypertension management, smoking cessation, dietary risks
• Tuberculosiso Second highest cause of burden, despite reductions in mortality
o Opportunities for intervention: increased case detection, prevention strategies
• Road traffic injurieso Third highest cause of burden, still increasing
o Opportunities for intervention: road engineering, helmet/seatbelt law enforcement, vehicle safety standards
• Diabetes and Chronic Kidney Diseaseo Rapid rise in both since 1990
o Opportunities for intervention: improved prevention and management in primary care
63
Implications for Indonesia
• Large variation across geography and socioeconomic status in Indonesia warrants a closer look to determine the people and communities at highest risk of health burden.
• Indonesia needs better control of major risk factors, especially dietary risk factors like low fruit intake.
• Road traffic injuries continue to contribute substantially to national health burden and require efforts by the health and transportation sectors to reduce burden.
• Communicable diseases need to be addressed also, especially tuberculosis, diarrhea, vaccine-preventable diseases, typhoid, malaria, and HIV.
GBD goes on…
• Shifting to annual updates of burden – next one: 2014 with estimates up to 2013
• Continue to update the data, methods and computational infrastructure
• IHME works closely with countries to update, revise and increase the utility of GBD measurements for policy making
• Critical next step for countries: transition to subnational measurements of burden of disease
• Planning to add health expenditure by disease
64
…to subnational Indonesia!
• Subnational estimates for burden of disease by province in Indonesia will be included in GBD 2015.
• Subset of diseases will get extra focus:
65
• Stroke• Ischemic heart disease• Tuberculosis• Diabetes• Cancer• COPD• Road traffic injuries• Lower respiratory infections (and
etiologies)
• Diarrhea (and etiologies)
• Maternal conditions• Malaria• Dengue• HIV• Leprosy• Yaws• Perhaps more . . .